A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC

NCT03092895 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

157

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Primary Liver Cancer
Advanced Biliary Tract Carcinoma

Interventions

BIOLOGICAL: SHR-1210
DRUG: Apatinib
DRUG: FOLFOX4
DRUG: GEMOX

Sponsor

Jiangsu HengRui Medicine Co., Ltd.